Best treatments for alzheimer disease
10 products may treat alzheimer disease, spanning FDA drug classes such as cholinesterase inhibitor, monoamine oxidase inhibitor, monoamine oxidase type b inhibitor. The current highest-rated option is donepezil hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 10 drugs we list for alzheimer disease, 6 are available as lower-cost generics, spanning classes such as cholinesterase inhibitor, monoamine oxidase inhibitor, monoamine oxidase type b inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for alzheimer disease — so confirm the right choice with your prescriber.
Understanding alzheimer disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills and, over time, the ability to carry out the simplest tasks. It is the most common cause of dementia among older adults, and in most people symptoms first appear later in life (NIA). In the brain, abnormal clumps called amyloid plaques and tangled fibers called tau (neurofibrillary) tangles build up, and neurons lose connections with one another and eventually die (NIA). Trouble remembering recent events or names is often an early sign; the disease begins slowly over many years and progresses in stages, later bringing difficulty speaking, reading, or writing, getting lost in familiar places, and changes in mood and behavior, until a person may eventually need total care (MedlinePlus). To evaluate it, doctors ask about health and daily activities, test memory, problem-solving, attention, and language, run blood and other standard tests to help rule out other causes, and may use brain scans such as CT, MRI, or PET (NIA). No treatment can stop the disease, but some medicines may help ease symptoms for a limited time (MedlinePlus). This is general information, not medical advice.
First-line treatment
For mild-to-moderate Alzheimer's disease, the UK NICE guideline (NG97) recommends the three acetylcholinesterase (AChE) inhibitors—donepezil, galantamine, and rivastigmine—as monotherapy options; treatment should be started only on the advice of a clinician with the necessary expertise (NICE NG97). NICE advises considering memantine, an NMDA-receptor medicine, in addition to an AChE inhibitor for people with moderate disease, and offering memantine added to an AChE inhibitor for severe disease; memantine on its own is an option for people who cannot tolerate or have a contraindication to AChE inhibitors (NICE NG97). Non-drug support such as group cognitive stimulation therapy is also offered (NHS, NICE NG97). Because response, other health conditions, and tolerability vary from person to person, a clinician individualizes the choice, monitors the effect, and reviews treatment over time. This is general information, not medical advice.
Top-rated picks for alzheimer disease: 1. Donepezil Hydrochloride · 2. Kisunla · 3. Galantamine Hydrobromide
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | Cholinesterase Inhibitor | Generic | $1 | View → | |
| 2 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 3 | 66/100 | Prescription | Capsule | Cholinesterase Inhibitor | Generic | $27 | View → | |
| 4 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 5 | Not yet rated | Prescription | Patch | Monoamine Oxidase Inhibitor | Generic | $20 | View → | |
| 6 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 7 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 8 | Not yet rated | Prescription | Capsule | N-methyl-D-aspartate Receptor Antagonist | Generic | $2 | View → | |
| 9 | Not yet rated | Prescription | Capsule | Cholinesterase Inhibitor | Generic | $6 | View → | |
| 10 | Not yet rated | Prescription | Tablet | Monoamine Oxidase Inhibitor | Generic | $20 | View → |
Narrow by drug class
Explore the class hubs: cholinesterase inhibitor · monoamine oxidase inhibitor
Full ranking · 10 treatments
donepezil hydrochloride
PrescriptionFDA-sourced
Donepezil Hydrochloride is a cholinesterase inhibitor used to treat Alzheimer Disease.
Pharmacy pays
From ~$1.32/30· 5 formskisunla
Boxed warningPrescriptionFDA-sourced
Kisunla (Donanemab-Azbt) is a medication used to treat Alzheimer Disease, Neurocognitive Disorders.
Price varies
galantamine hydrobromide
PrescriptionFDA-sourced
Galantamine Hydrobromide is a cholinesterase inhibitor used to treat Alzheimer Disease.
Pharmacy pays
From ~$24.44/30· 3 forms Save up to 95% in classaduhelm
PrescriptionFDA-sourced
Aduhelm (Aducanumab-Avwa) is a medication used to treat Alzheimer Disease.
Price varies
emsam
PrescriptionFDA-sourced
Emsam (Selegiline) is a monoamine oxidase inhibitor used to treat Alzheimer Disease, Attention Deficit Disorder with Hyperactivity, Depressive Disorder, Parkinson Disease.
Pharmacy pays
From ~$19.44/30· 2 forms Save up to 10% in classleqembi
Boxed warningPrescriptionFDA-sourced
Leqembi (Lecanemab-Irmb) is a medication used to treat Alzheimer Disease.
Price varies
Frequently asked
- What treats alzheimer disease?
- Our catalog lists 10 products that may treat alzheimer disease, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is donepezil hydrochloride.
- What is the best-rated treatment for alzheimer disease?
- By our independent recall-safety rating — not an efficacy measure — donepezil hydrochloride ranks highest among the products we list for alzheimer disease. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat alzheimer disease?
- Treatments for alzheimer disease span FDA drug classes including cholinesterase inhibitor, monoamine oxidase inhibitor, monoamine oxidase type b inhibitor, n-methyl-d-aspartate receptor antagonist. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Sources
The clinical overview above is written from these authoritative public-health and medical-society sources, independently reviewed against each.
- Alzheimer's Disease Fact Sheet, National Institute on Aging (NIA/NIH) ↗
- How Is Alzheimer's Disease Diagnosed?, National Institute on Aging (NIA/NIH) ↗
- Alzheimer's Disease, MedlinePlus (U.S. National Library of Medicine) ↗
- Dementia: assessment, management and support (NG97), Recommendations, National Institute for Health and Care Excellence (NICE) ↗
- Alzheimer's disease — Treatment, NHS (UK) ↗